Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Endo

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Pancreas|July 25, 2014
Major and minor duodenal papillae in autoimmune pancreatitisKazuro Chiba, Terumi Kamisawa, Sawako Kuruma, et al.
Breast Cancer Research and Treatment|May 26, 2024
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational studyAyaka Isogai, Kazuki Nozawa, Akira Nakakami, et al.
Surgical Case Reports|June 21, 2023
Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case reportAyaka Isogai, Haruru Kotani, Masataka Sawaki, et al.
In Vitro Cellular & Developmental Biology. Animal|February 25, 2026
Direct reprogramming of Müller glia into photoreceptors via multiple transcription factors and small molecules: molecular mechanisms and transcriptomic analysisYuka Endo, Eriko Sugano, Yuko Seko, et al.
Molecular and Clinical Oncology|June 6, 2020
Utility of regional nodal irradiation in Japanese patients with breast cancer with 1-3 positive nodes after breast-conserving surgery and axillary lymph-node dissectionNaomi Gondo, Masataka Sawaki, Masaya Hattori, et al.
Journal of Breast Cancer|August 29, 2022
Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor UseYuka Endo, Akiyo Yoshimura, Masataka Sawaki, et al.
Breast Cancer (Tokyo, Japan)|October 8, 2021
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR statusNanae Horisawa, Yayoi Adachi, Daiki Takatsuka, et al.
Carcinogenesis|January 28, 2014
Targeted deletion of RasGRP1 impairs skin tumorigenesisAmrish Sharma, Lauren L Fonseca, Cynthia Rajani, et al.
Annals of Surgical Oncology|February 8, 2023
The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II TrialAyumi Kataoka, Masataka Sawaki, Nanae Horisawa, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 6, 2016
Caspase-1 deficiency promotes high-fat diet-induced adipose tissue inflammation and the development of obesityHiroaki Kimura, Tadayoshi Karasawa, Fumitake Usui, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Pancreas|July 25, 2014
Major and minor duodenal papillae in autoimmune pancreatitisKazuro Chiba, Terumi Kamisawa, Sawako Kuruma, et al.
Breast Cancer Research and Treatment|May 26, 2024
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational studyAyaka Isogai, Kazuki Nozawa, Akira Nakakami, et al.
Surgical Case Reports|June 21, 2023
Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case reportAyaka Isogai, Haruru Kotani, Masataka Sawaki, et al.
In Vitro Cellular & Developmental Biology. Animal|February 25, 2026
Direct reprogramming of Müller glia into photoreceptors via multiple transcription factors and small molecules: molecular mechanisms and transcriptomic analysisYuka Endo, Eriko Sugano, Yuko Seko, et al.
Molecular and Clinical Oncology|June 6, 2020
Utility of regional nodal irradiation in Japanese patients with breast cancer with 1-3 positive nodes after breast-conserving surgery and axillary lymph-node dissectionNaomi Gondo, Masataka Sawaki, Masaya Hattori, et al.
Journal of Breast Cancer|August 29, 2022
Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor UseYuka Endo, Akiyo Yoshimura, Masataka Sawaki, et al.
Breast Cancer (Tokyo, Japan)|October 8, 2021
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR statusNanae Horisawa, Yayoi Adachi, Daiki Takatsuka, et al.
Carcinogenesis|January 28, 2014
Targeted deletion of RasGRP1 impairs skin tumorigenesisAmrish Sharma, Lauren L Fonseca, Cynthia Rajani, et al.
Annals of Surgical Oncology|February 8, 2023
The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II TrialAyumi Kataoka, Masataka Sawaki, Nanae Horisawa, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 6, 2016
Caspase-1 deficiency promotes high-fat diet-induced adipose tissue inflammation and the development of obesityHiroaki Kimura, Tadayoshi Karasawa, Fumitake Usui, et al.
Pageof 6